M&A - Viatris - Pacira BioSciences
October 08, 2026
Pharmaceutical company Viatris intends to buy non-opioid pain medicine creator Pacira BioSciences for $1.65 billion.To add details to this portfolio regarding legal or economic representatives, please contact editors@mlex.com